Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Minocycline protects against microgliopathy in a Csf1r haplo-insufficient mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)

31 May 2023

Abstract excerpt

Abstract Background Mutations in colony-stimulating factor 1 receptor (CSF1R) are known to cause adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), which has been recently demonstrated as a primary microgliopathy characterized by cognitive impairment. Although the molecular mechanism underlying CSF1R-mediated microgliopathy remains unclear, therapeutic strategies have generally...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurogenesis and neuroplasticity mechanisms
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Parkinson's Disease Mechanisms and Treatments

Source

Identifiers

PMID: 37259140
DOI: 10.1186/s12974-023-02774-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Minocycline protects against microgliopathy in a Csf1r haplo-insufficient mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)PMID 37259140Read ↗

Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).Semantic proximity Read ↗

Colony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo.Semantic proximity Read ↗

An adapted stem cell-derived microglia protocol for the study of microgliopathies and other neurological disordersSemantic proximity Read ↗

Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy.Semantic proximity Read ↗

The effect of a dominant kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy on brain development and neuropathology.Semantic proximity Read ↗

CSF1R -related leukoencephalopathySemantic proximity Read ↗

The effect of a dominant kinase-dead <i>Csf1r</i> mutation associated with adult-onset leukoencephalopathy on brain development and neuropathologySemantic proximity Read ↗

Microglia replacement effectively attenuates the disease progress of ALSP in the mouse model and human patientSemantic proximity Read ↗

Microglial homeostasis requires balanced CSF-1/CSF-2 receptor signalingSemantic proximity Read ↗

Dominant-acting CSF1R variants cause microglial depletion and altered astrocytic phenotype in zebrafish and adult-onset leukodystrophy.Semantic proximity Read ↗

CSF1R-related leukoencephalopathy: experimental models and potential for treatment.Semantic proximity Read ↗

A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.